NOVEMBERASIA BUSINESS OUTLOOK19artificial intelligence (AI) and genomics to predict treatment outcomes in cases of remission, relapse, or survival duration for patients receiving advanced therapies.Its experts in genetic mapping use predictive algorithms to forecast disease progression and treatment response. This helps identify potential side effects in advance, enabling safer and more personalized treatment plans.By blending biological science, AI, and genetics, Ascendnex is building a more intelligent and adaptive healthcare model, ensuring that every patient benefits from data-driven insights and the most advanced precision therapies available. Backbone of ExcellenceAscendnex draws its consulting strength from a highly multidisciplinary core team led by its founder. The team includes a strong network of medical professionals, scientists, and business experts, creating a well-rounded foundation for both scientific and strategic consulting.The consulting division is spearheaded by the Founder, Dr Karthik Chandran, supported by qualified doctors including oncologists, orthopedic surgeons, and hematologists. The doctors bring deep clinical insight into cancer treatment, regenerative medicine, and orthopedic care. Alongside them, the team includes statisticians, clinical research officers (CROs), and entrepreneurs with proven experience in company management and operations.On the laboratory and medical device side, Ascendnex employs a team of eight to nine PhD holders with advanced expertise in research and product development. Additionally, the company also maintains international collaborations with institutions and experts from China, Russia, Turkey, the United States, and the United Kingdom, providing technical support and access to specialized equipment.Together, this global and multidisciplinary team delivers holistic consulting solutions that combine scientific excellence, regulatory understanding, and business intelligence which strengthens Ascendnex 's position as a trusted partner in the life sciences industry. The Path for the FutureHaving already evolved from consultancy to medical device and cell and gene therapy manufacturing, Ascendnex now aims to strengthen its presence across multiple facets of modern medicine.Looking forward, Ascendnex aims to build a sustainable, patient-centric ecosystem that combines technological advancement with social responsibility, by growing not just in scale, but in purpose, impact and contribution to global health. Karthik concludes by stating "We envision becoming a global leader by challenging the rising cost of healthcare by reducing production expenses and ensuring affordable access to advanced treatments".
< Page 9 | Page 11 >